✦ LIBER ✦

Discovery process and pharmacological characterization of a novel dual orexin 1 and orexin 2 receptor antagonist useful for treatment of sleep disorders

✍ Scribed by Romano Di Fabio; Annalisa Pellacani; Stefania Faedo; Adelheid Roth; Laura Piccoli; Philip Gerrard; Rod A. Porter; Christopher N. Johnson; Kevin Thewlis; Daniele Donati; Luigi Stasi; Simone Spada; Geoffrey Stemp; David Nash; Clive Branch; Leanda Kindon; Mario Massagrande; Alessandro Poffe; Simone Braggio; Elisabetta Chiarparin; Carla Marchioro; Emiliangelo Ratti; Mauro Corsi

Book ID: 113495904
Publisher: Elsevier Science
Year: 2011
Tongue: English
Weight: 476 KB
Volume: 21
Category: Article
ISSN: 0960-894X
DOI: 10.1016/j.bmcl.2011.06.086

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Discovery of [(2R,5R)-5-{[(5-Fluoropyrid

Discovery of [(2R,5R)-5-{[(5-Fluoropyridin-2-yl)oxy]methyl}-2-methylpiperidin-1-yl][5-methyl-2-(pyrimidin-2-yl)phenyl]methanone (MK-6096): A Dual Orexin Receptor Antagonist with Potent Sleep-Promoting Properties

✍ Dr. Paul J. Coleman; John D. Schreier; Dr. Christopher D. Cox; Michael J. Bresli 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 445 KB

Pharmacological Profile of KP-496, a Nov

Pharmacological Profile of KP-496, a Novel Dual Antagonist for Cysteinyl Leukotriene Receptor (CysLT1R) and Thromboxane A2 Receptor (TP)

✍ Ishimura, M.; Suda, M.; Kataoka, S.; Maeda, T.; Hiyama, Y. 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 158 KB

Cover Picture: Discovery of [(2R,5R)-5-{

Cover Picture: Discovery of [(2R,5R)-5-{[(5-Fluoropyridin-2-yl)oxy]methyl}-2-methylpiperidin-1-yl][5-methyl-2-(pyrimidin-2-yl)phenyl]methanone (MK-6096): A Dual Orexin Receptor Antagonist with Potent Sleep-Promoting Properties (ChemMedChem 3/2012)

✍ Dr. Paul J. Coleman; John D. Schreier; Dr. Christopher D. Cox; Michael J. Bresli 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 754 KB

Pharmacological Characterization of MK-0

Pharmacological Characterization of MK-0974 [N-[(3R,6S)-6-(2,3-Difluorophenyl)-2-oxo-1-(2,2,2-trifluoroethyl)azepan-3-yl]-4-(2-oxo-2,3-dihydro-1H-imidazo[4,5-b]pyridin-1-yl)piperidine-1-carboxamide], a Potent and Orally Active Calcitonin Gene-Related Peptide Receptor Antagonist for the Treatment of Migraine

✍ Salvatore, C. A.; Hershey, J. C.; Corcoran, H. A.; Fay, J. F.; Johnston, V. K.; 📂 Article 📅 2007 🏛 American Society for Pharmacology and Experimental 🌐 English ⚖ 370 KB